Phathom Pharmaceuticals, Inc. (PHAT)
Nasdaq: PHAT · CIK 0001783183 · United States
Every official Phathom Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open PHAT filings
Phathom Pharmaceuticals, Inc. documents
- Phathom Pharmaceuticals, Inc. 10-K 2026PHAT 10-K 2026: annual report for fiscal 2026
- Phathom Pharmaceuticals, Inc. 10-K 2025PHAT 10-K 2025: annual report for fiscal 2025
- Phathom Pharmaceuticals, Inc. 10-K 2024PHAT 10-K 2024: annual report for fiscal 2024
- Phathom Pharmaceuticals, Inc. 10-K 2023PHAT 10-K 2023: annual report for fiscal 2023
- Phathom Pharmaceuticals, Inc. 10-K 2022PHAT 10-K 2022: annual report for fiscal 2022
- Phathom Pharmaceuticals, Inc. 10-Q 2026PHAT 10-Q 2026: quarterly report for fiscal 2026
- Phathom Pharmaceuticals, Inc. 10-Q 2025PHAT 10-Q 2025: quarterly report for fiscal 2025
- Phathom Pharmaceuticals, Inc. 10-Q 2024PHAT 10-Q 2024: quarterly report for fiscal 2024
- Phathom Pharmaceuticals, Inc. 10-Q 2023PHAT 10-Q 2023: quarterly report for fiscal 2023
- Phathom Pharmaceuticals, Inc. 10-Q 2022PHAT 10-Q 2022: quarterly report for fiscal 2022
- Phathom Pharmaceuticals, Inc. 8-K 2026PHAT 8-K 2026: current report for fiscal 2026
- Phathom Pharmaceuticals, Inc. 8-K 2025PHAT 8-K 2025: current report for fiscal 2025
- Phathom Pharmaceuticals, Inc. 8-K 2024PHAT 8-K 2024: current report for fiscal 2024
- Phathom Pharmaceuticals, Inc. 8-K 2023PHAT 8-K 2023: current report for fiscal 2023
- Phathom Pharmaceuticals, Inc. 8-K 2022PHAT 8-K 2022: current report for fiscal 2022
- Phathom Pharmaceuticals, Inc. DEF 14A 2026PHAT DEF 14A 2026: proxy statement for fiscal 2026
- Phathom Pharmaceuticals, Inc. DEF 14A 2025PHAT DEF 14A 2025: proxy statement for fiscal 2025
- Phathom Pharmaceuticals, Inc. DEF 14A 2024PHAT DEF 14A 2024: proxy statement for fiscal 2024
- Phathom Pharmaceuticals, Inc. DEF 14A 2023PHAT DEF 14A 2023: proxy statement for fiscal 2023
- Phathom Pharmaceuticals, Inc. DEF 14A 2022PHAT DEF 14A 2022: proxy statement for fiscal 2022
- Phathom Pharmaceuticals, Inc. Form 4 2026PHAT Form 4 2026: insider trading filing for fiscal 2026
- Phathom Pharmaceuticals, Inc. Form 4 2025PHAT Form 4 2025: insider trading filing for fiscal 2025
- Phathom Pharmaceuticals, Inc. Form 4 2024PHAT Form 4 2024: insider trading filing for fiscal 2024
- Phathom Pharmaceuticals, Inc. Form 4 2023PHAT Form 4 2023: insider trading filing for fiscal 2023
- Phathom Pharmaceuticals, Inc. Form 4 2022PHAT Form 4 2022: insider trading filing for fiscal 2022
- Phathom Pharmaceuticals, Inc. S-1 2026PHAT S-1 2026: registration statement for fiscal 2026
- Phathom Pharmaceuticals, Inc. S-1 2025PHAT S-1 2025: registration statement for fiscal 2025
- Phathom Pharmaceuticals, Inc. S-1 2024PHAT S-1 2024: registration statement for fiscal 2024
- Phathom Pharmaceuticals, Inc. S-1 2023PHAT S-1 2023: registration statement for fiscal 2023
- Phathom Pharmaceuticals, Inc. S-1 2022PHAT S-1 2022: registration statement for fiscal 2022
- Phathom Pharmaceuticals, Inc. 13F 2026PHAT 13F 2026: institutional holdings for fiscal 2026
- Phathom Pharmaceuticals, Inc. 13F 2025PHAT 13F 2025: institutional holdings for fiscal 2025
- Phathom Pharmaceuticals, Inc. 13F 2024PHAT 13F 2024: institutional holdings for fiscal 2024
- Phathom Pharmaceuticals, Inc. 13F 2023PHAT 13F 2023: institutional holdings for fiscal 2023
- Phathom Pharmaceuticals, Inc. 13F 2022PHAT 13F 2022: institutional holdings for fiscal 2022
More companies